PSYBF (PsyBio Therapeutics) Other Current Liabilities: $0.04 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PsyBio Therapeutics Other Current Liabilities?

PsyBio Therapeutics PSYBF -90.00% Other Current Liabilities is $0.04 Mil as of Jun. 2023.

PsyBio Therapeutics's other current liabilities for the quarter that ended in Jun. 2023 was $0.04 Mil.

PsyBio Therapeutics's quarterly other current liabilities declined from Dec. 2022 ($0.01 Mil) to Mar. 2023 ($0.01 Mil) but then increased from Mar. 2023 ($0.01 Mil) to Jun. 2023 ($0.04 Mil).

PsyBio Therapeutics's annual other current liabilities stayed the same from . 20 ($0.00 Mil) to Dec. 2021 ($0.00 Mil) but then increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.01 Mil).

PsyBio Therapeutics Other Current Liabilities Related Terms

PsyBio Therapeutics Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for PsyBio Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PsyBio Therapeutics Other Current Liabilities Chart

PsyBio Therapeutics Annual Data
Trend Dec21 Dec22
Other Current Liabilities
0.00 0.01

PsyBio Therapeutics Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.08 0.01 0.01 0.04

PsyBio Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.04 Mil mean?
PsyBio Therapeutics (PSYBF) has a Other Current Liabilities of $0.04 Mil as of Jun. 2023. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on PsyBio Therapeutics.
Is PsyBio Therapeutics' Other Current Liabilities too high?
PsyBio Therapeutics' current Other Current Liabilities is $0.04 Mil.
How does PsyBio Therapeutics' Other Current Liabilities compare to VRTX and REGN?
PsyBio Therapeutics' Other Current Liabilities of $0.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on PsyBio Therapeutics. PsyBio Therapeutics's current Other Current Liabilities is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PsyBio Therapeutics stock overvalued right now?
PsyBio Therapeutics (PSYBF) has a current Other Current Liabilities of $0.04 Mil. The current Other Current Liabilities is $0.04 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For PsyBio Therapeutics (PSYBF), the current Other Current Liabilities is $0.04 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PsyBio Therapeutics Business Description

Address 1624 Washington Street, Denver, CO, USA, 80203
PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.